Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mirro, J.
Right arrow Articles by Zipf, T. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mirro, J.
Right arrow Articles by Zipf, T. F.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Clinical and laboratory characteristics of acute leukemia with the 4;11 translocation

J Mirro, G Kitchingman, D Williams, GJ Lauzon, CC Lin, T Callihan and TF Zipf

This report describes the clinical and laboratory features of seven cases of acute leukemia associated with the 4;11 chromosomal translocation. All seven children had acute lymphoblastic leukemia by standard morphologic and cytochemical criteria. Leukemic blasts from six of seven patients were terminal deoxynucleotidyl transferase- positive. Immunologic phenotyping suggested the leukemias were of B cell origin; blasts from five patients expressed HLA-DR and p24 (CD-9 antibody), blasts from three patients expressed B4 (CD-19), and blasts from two patients expressed the common acute lymphoblastic leukemia antigen (CD-10). One patient's leukemic blasts contained cytoplasmic immunoglobulin. Analysis of DNA from four of five patients demonstrated additional evidence of B cell differentiation with heavy-chain immunoglobulin gene rearrangement. When DNA from the four patients with heavy-chain immunoglobulin gene rearrangement was analyzed, one patient's DNA demonstrated light-chain immunoglobulin gene rearrangement. However, flow cytometric analysis of blasts from three patients showed the simultaneous expression of the lymphoid-associated antigen B4 (CD-19) and the myeloid-associated antigen My-1 (X-Hapten). Electron microscopic examination of blasts from one patient that expressed both lymphoid- and myeloid-associated antigens demonstrated ultrastructural characteristics of both lineages. These findings suggest that acute leukemia with the t(4;11) abnormality has mixed lineage characteristics as a result of leukemogenesis in a multipotential progenitor cell or aberrant gene expression later in differentiation. Furthermore, serial analysis of karyotype, immunophenotype, and heavy-chain immunoglobulin genes revealed changes in these biologic markers over time, suggesting continued chromosome rearrangement and gene modulation after the leukemogenic event in cells with the t(4;11).

Volume 67, Issue 3, pp. 689-697, 03/01/1986
Copyright © 1986 by The American Society of Hematology


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
haematolHome page
R. K. Slany
The molecular biology of mixed lineage leukemia
Haematologica, July 1, 2009; 94(7): 984 - 993.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
F. E. Bertrand, C. Vogtenhuber, N. Shah, and T. W. LeBien
Pro-B-cell to pre-B-cell development in B-lineage acute lymphoblastic leukemia expressing the MLL/AF4 fusion protein
Blood, December 1, 2001; 98(12): 3398 - 3405.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
C. A. Felix and B. J. Lange
Leukemia in Infants
Oncologist, June 1, 1999; 4(3): 225 - 240.
[Abstract] [Full Text]


Home page
BloodHome page
W.-D. Ludwig, H. Rieder, C. R. Bartram, B. Heinze, S. Schwartz, W. Gassmann, H. Loffler, D. Hossfeld, G. Heil, S. Handt, et al.
Immunophenotypic and Genotypic Features, Clinical Characteristics, and Treatment Outcome of Adult Pro-B Acute Lymphoblastic Leukemia: Results of the German Multicenter Trials GMALL 03/87 and 04/89
Blood, September 15, 1998; 92(6): 1898 - 1909.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
G. Ott, J. Kalla, A. Steinhoff, A. Rosenwald, T. Katzenberger, U. Roblick, M. M. Ott, and H. K. Muller-Hermelink
Trisomy 3 Is Not a Common Feature in Malignant Lymphomas of Mucosa-Associated Lymphoid Tissue Type
Am. J. Pathol., September 1, 1998; 153(3): 689 - 694.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
H. P. KOEFFLER
Syndromes of Acute Nonlymphocytic Leukemia
Ann Intern Med, November 1, 1987; 107(5): 748 - 758.
[Abstract] [PDF]


Home page
ScienceHome page
C. Denny, G. Hollis, F Hecht, R Morgan, M. Link, S. Smith, and I. Kirsch
Common mechanism of chromosome inversion in B- and T-cell tumors: relevance to lymphoid development
Science, October 10, 1986; 234(4773): 197 - 200.
[Abstract] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1986 by American Society of Hematology         Online ISSN: 1528-0020